Topic
Private Credit
Coverage of private credit markets and direct lending. Research includes fund flows, redemption pressures, leverage structures, and spillovers to public credit markets.
2202 reports available
How to Diversify With Alternatives
Alternative investments continue to serve as vital tools for portfolio diversification and long-term returns, though current geopolitical risks necessitate a highly selective approach across hedge funds and private markets.
Use Equity Market Strength to Rebalance
UBS recommends rebalancing equity gains into bonds and structured products as the S&P 500 hits record highs, while shifting focus toward diversifying beyond US tech megacaps.
Fundamentals Remain Solid Amid Uncertainty
UBS maintains an optimistic outlook on global equities, targeting an S&P 500 level of 7,900 by year-end despite sticky inflation pushing Fed rate cut expectations to December. Strength in corporate earnings and AI adoption remain the primary drivers of market performance.
Strategy Outlook
UBS Asset Management shifts its hedge fund outlook toward a stagflationary scenario triggered by Middle East conflict and supply chain disruptions. The firm is increasing focus on relative value strategies to mitigate heightened correlation instability between asset classes.
US Semiconductors BofA Global Tech Conference Preview
This report previews the BofA Global Tech Conference, forecasting that the AI data center TAM will grow to over $1.7 trillion by 2030. It highlights key debates in memory supply, analog recovery, and the durability of the AI capex cycle.
How Innovation is Transforming Biotechnology
Biotechnology is entering a multi-year innovation cycle driven by five key trends: scalable gene therapies, multi-purpose drugs, efficient regulatory pathways, AI-driven discovery, and precise drug delivery. These advancements are increasing R&D productivity and expanding addressable markets, making the sector an attractive compounding asset class.